Press Releases

Date Title and Summary Additional Formats
Toggle Summary Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement
SOLANA BEACH, Calif. , July 07, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), today announced that it has entered into a master service agreement with inVentiv Commercial Services LLC ("inVentiv") in connection with Evoke's preparation for commercial activities for EVK-001, its lead
View HTML
Toggle Summary Evoke Accelerates New Drug Application Process by Engaging Regulatory Experts
NDA Preparation Initiates as EVK-001 Nears Phase 3 Study Completion
View HTML